2023 annual financial data
Biodexa Pharmaceuticals 2023 Operating margin
Direct answer
Operating margin was -2,103.41%.
Operating income was -8,014,000 GBP and net income was -7,079,000 GBP.
Operating cash flow was -6,826,000 GBP.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 381,000 GBP
- Operating income
- -8,014,000 GBP
- Net income
- -7,079,000 GBP
- Operating cash flow
- -6,826,000 GBP